SCHEDULE 13G/A: Armistice Capital Discloses 4.99% Passive Stake in Aspira Women's Health

Armistice Capital, LLC and Steven Boyd have disclosed a passive beneficial ownership of 4.99% in Aspira Women's Health Inc., totaling 800,797 shares as of December 31, 2024.

Summary

• Armistice Capital, LLC and Steven Boyd, collectively referred to as the 'Reporting Persons,' have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Aspira Women's Health Inc.
• As of December 31, 2024, the Reporting Persons beneficially own an aggregate of 800,797 shares of Aspira Women's Health Inc. common stock.
• This ownership represents 4.99% of the total class of securities.
• Both Armistice Capital, LLC and Steven Boyd hold shared voting power and shared dispositive power over all 800,797 shares.
• Armistice Capital, LLC, a Delaware entity, acts as the investment manager for Armistice Capital Master Fund Ltd., which is the direct holder of the shares.
• Steven Boyd, a U.S. citizen, is the managing member of Armistice Capital, LLC and is deemed to beneficially own the securities held by the Master Fund.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose or with the effect of changing or influencing the control of the issuer.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing is a routine disclosure of a passive stake by an institutional investor, which is generally viewed as a neutral to positive signal of continued interest, without indicating any new operational or financial developments.

Positives

• The disclosure of a significant, albeit passive, stake by an institutional investor like Armistice Capital may signal confidence in Aspira Women's Health Inc.'s long-term prospects.
• The explicit statement that the shares are held for passive investment purposes, and not to influence control, can reassure the market by reducing concerns about potential activist interventions.

Negatives

• The ownership percentage of 4.99% is just below the 5% threshold, which allows the investor to file a Schedule 13G (passive intent) rather than a Schedule 13D (active intent), potentially limiting transparency regarding future intentions if the stake were to increase.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of beneficial ownership by an institutional investor and does not provide specific insights into broader industry trends or competitive dynamics for Aspira Women's Health Inc.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, which can influence investor sentiment and perception of the company's stability and attractiveness to large funds.

Key Dates

Keywords

Aspira Women's Health, Armistice Capital, Steven Boyd, Schedule 13G, beneficial ownership, common stock, institutional investment, passive investment